MAPT and Alzheimer disease: BACE1 protein concentrations, probably reflecting levels of gene expression, and rates of enzymatic activity, have been measured in human CSF samples to investigate their diagnostic/predictive values as well as their association with critical pathophysiological alterations of AD, including the amyloid-β pathway, tau pathophysiology, neurodegeneration, and synaptic dysfunction [3].